Durham.

PositionTriangle

DURHAM -- Voyager Pharmaceutical renamed itself Curaxis Pharmaceutical after raising $25 million from Connecticut-based investment firm Southridge Partners. With it, the drug developer will restart clinical trials...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT